Pharmafile Logo
Pharmafocus logo
Advanced Search

XOMA acquires royalty and milestone rights for NPC and pancreatic cancer assets

June 23, 2023
Sales and Marketing Cancer, Oncology, Xoma, acquisition, oncology

US-based biotechnology royalty aggregator XOMA has announced that it has gained the royalty and milestone rights for two assets from …

News
money-pills-pharma-file

GSK settles first Zantac lawsuit due for trial in US

June 23, 2023
Medical Communications Cancer, GSK, Pharmacy, Zantac, lawsuit

UK-based pharmaceutical and biotechnology company GSK has reached a settlement with a US man who claims the drugmaker’s heartburn medicine …

News
inhaler-2520472_960_720

Lupin Healthcare launches Beclu carbon neutral inhalers for asthma treatment

June 22, 2023
Research and Development Asthma & COPD, Beclu, Lupin Healthcare, asthma, carbon neutral, inhaler

UK-based subsidiary of Lupin Limited, Lupin Healthcare, has announced the UK launch of its carbon neutral pressurised metered dose inhalers …

News

FDA approves new medicines to treat paediatric type 2 diabetes

June 22, 2023
Medical Communications Diabetes, FDA, Synjardy, jardiance, paediatrics, type 2 diabetes

The US Food and Drug Administration (FDA) has announced that it has approved Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin …

News

Hyloris enrols first patient in four-arm clinical trial

June 22, 2023
Research and Development Genito-Urinary system, Hyloris, bladder pain, clinical trial, cystitis

Belgian specialty biopharmaceutical company Hyloris has announced that it has enrolled the first patient in its four-arm interstitial cystitis/bladder pain …

News
money_pills_2

Zymeworks to open new EU HQ in Dublin, Ireland

June 22, 2023
Business Services Dublin, Oncology, Zymeworks, headquarters, regulatory affiars

Canadian biotech company Zymeworks has announced plans to open its new Clinical and Regulatory EU headquarters in Dublin, Ireland. Zymework …

News

Eli Lilly to acquire DICE Therapeutics for immunology innovations

June 21, 2023
Business Services DICE Therapeutics, Eli Lilly, Immunology, acquisition, immunology

Eli Lilly and DICE Therapeutics have announced a definitive agreement for Lilly to acquire DICE, a biopharmaceutical company focusing on …

News
mufid-majnun-cm1au42fnrg-unsplash_3

GSK shares positive data for RSV vaccine

June 21, 2023
Research and Development GSK, Immunology, RSV, Vaccine, clinical trial

GSK have announced new positive data from the AReSVi-006 phase 3 trial which assessed the efficacy of a single dose …

News
national-cancer-institute-kmvohcb-w5g-unsplash_1

FDA approves Pfizer’s HRR mCRPC drug

June 21, 2023
Medical Communications FDA, Oncology, Pfizer, breast cancer, oncology, prostate cancer

US-based pharmaceutical and biotechnology company Pfizer has announced that the US Food and Drug Administration (FDA) has approved its homologous …

News

PharmaTher and Vitruvias sign collaboration agreement to commercialise ketamine-based treatment in the US

June 21, 2023
Medical Communications Ketamine, Neurology, PharmaTher, Vitruvias, commercialisation

Specialty pharmaceutical companies, Canadian PharmaTher and US-based Vitruvias, have entered into a commercialisation partnership to bring Ketarx products to the …

News

Sirnaomics advances isSCC candidate into late-stage clinical development

June 20, 2023
Research and Development FDA, Oncology, Sirnaomics, clinical trial, isSCC

Global RNA therapeutics biopharmaceutical company Sirnaomics has announced that it has advanced its Squamous Cell Carcinoma in situ (isSCC) candidate …

News

Abu Dhabi’s Department of Health, M42 and AbbVie enter strategic partnership

June 20, 2023
Medical Communications AbbVie, Abu Dhabi, DoH, M42, Oncology, strategic partnership

Abu Dhabi’s Department of Health (DoH) has signed a Memorandum of Understanding (MoU) with AbbVie and M42 to advance research …

News

GSK announces extension of FDA’s review for momelotinib

June 20, 2023
Medical Communications FDA, GSK, Oncology, momelotinib, new drug application

GSK has announced that the US Food and Drug Administration (FDA) has extended its review period for the new drug …

News

Santhera and Catalyst Pharmaceuticals sign $231m license and collaboration deal

June 20, 2023
Medical Communications Catalyst Pharmaceuticals, Rare Diseases, Vamorolone, licence and collaboration, santhera

Swiss specialty pharmaceutical company Santhera and US-based biopharmaceutical company Catalyst Pharmaceuticals have announced that they have signed an exclusive license …

News

Immodulon appoints Josefine Roemmler-Zehrer as chief medical officer

June 20, 2023
Immodulon, Josefine Roemmler-Zehrer, appointment, chief medical officer

Cancer immunotherapy company Immodulon has announced that it has appointed Josefine Roemmler-Zehrer as chief medical officer, bringing with her vast …

Appointment

Scientists develop 3D printed pills for time-controlled release

June 19, 2023
Research and Development 3d printed pills, 3d printing, Max Planck Insititute, Pharmacy, University of California

A team of scientists at the Max Planck Institute (MPI) for Informatics, Germany, and the University of California, US, have …

News

Vaxxas opens manufacturing facility for needle-free vaccine patch

June 19, 2023
Research and Development Immunology, Vaxxas, manufacturing, needle-free vaccines, vaccines

Clinical stage biotech company Vaxxas has announced that it is opening a biomedical manufacturing facility in Brisbane, Australia, for the …

News

ImmuPharma initiates phase 2/3 clinical trial for lupus treatment

June 19, 2023
Research and Development Avion Pharmaceuticals, ImmuPharma, Immunology, Lupus, clinical trial

ImmuPharma has announced that it will commence a phase 2/3 adaptive clinical trial of P140 (Lupuzor) in patients with systemic …

News

Rani Therapeutics’ oral ‘robotic pill’ delivers injection trans-enterically

June 19, 2023
Medical Communications Osteoporosis, Rani Therapeutics, injection, osteoporosis, robotic pill, robotics

US Rani Therapeutics, a clinical-stage biotherapeutics company, has reported new results from its phase 1 trial into the RaniPill capsule …

News

LEO Pharma appoints Leanne Walsh as general manager and vice president for UK and Ireland

June 19, 2023
LEO Pharma, appointment, general manager, vice president

Medical dermatology company LEO Pharma has announced that it has appointed Leanne Walsh as its new general manager and vice …

Appointment
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026